Since our data showed that maternal-MSCs exhibited higher expression of GATA4 and MYOCD than that of middle-MSCs and fetal-MSCs, we hypothesized that maternal-MSCs may exert superior cardioprotective effects against MI injury. Here, MYOCD is linked to myocardial infarction.